Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2012.04.002
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2012
Authors
Publisher
Elsevier BV
Available in full text
August 1, 2012
Elsevier BV